[Remote] Rare Disease Sales Specialist - Chicago W IL at Axsome Therapeutics Inc

Remote

Axsome Therapeutics Inc Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

  • Team-oriented, goal-directed, and ownership mindset
  • Thrives in a collaborative, high-performance environment
  • Demonstrates grit, resilience, and determination in the face of challenges
  • Continuously strives to improve through feedback and learning
  • Strong business and market acumen
  • Ability to translate insights into actionable strategies and call plans
  • Advanced selling skills to influence HCP behavior
  • Ability to communicate complex clinical data clearly and engagingly

Responsibilities

  • Serve as the business owner for your territory, developing and executing a strategic plan to achieve or exceed sales targets
  • Identify, engage, and educate key healthcare professionals (HCPs), including nephrologists, nurse practitioners, and clinic staff
  • Build and maintain deep relationships across community and academic centers to support appropriate patient identification and treatment
  • Analyze territory dynamics to uncover growth opportunities and inform regional strategies
  • Deliver compelling, compliant clinical presentations to educate HCPs on atacicept’s mechanism of action, efficacy, safety, and patient benefits
  • Execute in-office and regional educational initiatives to enhance disease awareness and treatment understanding
  • Apply advanced selling skills to influence HCP behavior, foster accountability, and create urgency around patient care
  • Partner cross-functionally with Field Reimbursement, Medical Affairs, and Patient Support teams to ensure seamless patient access
  • Model Vera’s values of accountability, integrity, and compassion in every interaction
  • Collaborate with regional and cross-functional colleagues to ensure “One Vera” alignment in the field
  • Share best practices and insights to strengthen collective performance
  • Provide real-time feedback from the field to inform marketing and access strategies
  • Deliver consistent, compliant operational excellence

Skills

Sales
Rare Disease
Pharmaceutical Sales
Nephrology
IgA Nephropathy
Product Launch
Account Management
Key Opinion Leaders
Biotechnology

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters
2012Year Founded
$430.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Performance Bonus
Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.
Potential delays in AXS-07 launch amid growing market anticipation.
Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.
AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.
Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.
Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.
Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI